Logo image of EAD.DE

ERLEBNIS AKADEMIE AG (EAD.DE) Stock Fundamental Analysis

Europe - FRA:EAD - DE0001644565 - Common Stock

4.18 EUR
-0.12 (-2.79%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

4

EAD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 55 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of EAD is average, but there are quite some concerns on its profitability. EAD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EAD had negative earnings in the past year.
EAD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EAD reported negative net income in multiple years.
EAD had a positive operating cash flow in each of the past 5 years.
EAD.DE Yearly Net Income VS EBIT VS OCF VS FCFEAD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

EAD has a Return On Assets of -4.30%. This is in the lower half of the industry: EAD underperforms 69.09% of its industry peers.
The Return On Equity of EAD (-12.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.3%
ROE -12.32%
ROIC N/A
ROA(3y)-2.91%
ROA(5y)-1.16%
ROE(3y)-7.84%
ROE(5y)-3.13%
ROIC(3y)N/A
ROIC(5y)N/A
EAD.DE Yearly ROA, ROE, ROICEAD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

The Gross Margin of EAD (89.64%) is better than 87.27% of its industry peers.
EAD's Gross Margin has been stable in the last couple of years.
EAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y-1.44%
EAD.DE Yearly Profit, Operating, Gross MarginsEAD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

EAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
EAD has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for EAD has been increased compared to 5 years ago.
EAD has a better debt/assets ratio than last year.
EAD.DE Yearly Shares OutstandingEAD.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
EAD.DE Yearly Total Debt VS Total AssetsEAD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that EAD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.25, EAD perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
EAD has a debt to FCF ratio of 5.77. This is a neutral value as EAD would need 5.77 years to pay back of all of its debts.
EAD has a Debt to FCF ratio of 5.77. This is in the better half of the industry: EAD outperforms 61.82% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that EAD has dependencies on debt financing.
EAD's Debt to Equity ratio of 1.35 is in line compared to the rest of the industry. EAD outperforms 52.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 5.77
Altman-Z 1.25
ROIC/WACCN/A
WACC5.18%
EAD.DE Yearly LT Debt VS Equity VS FCFEAD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 3.31 indicates that EAD has no problem at all paying its short term obligations.
EAD's Current ratio of 3.31 is amongst the best of the industry. EAD outperforms 100.00% of its industry peers.
EAD has a Quick Ratio of 2.15. This indicates that EAD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EAD (2.15) is better than 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 2.15
EAD.DE Yearly Current Assets VS Current LiabilitesEAD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

3

3. Growth

3.1 Past

The earnings per share for EAD have decreased by -8.44% in the last year.
The Revenue has been growing slightly by 5.54% in the past year.
EAD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.80% yearly.
EPS 1Y (TTM)-8.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.29%
Revenue 1Y (TTM)5.54%
Revenue growth 3Y19.96%
Revenue growth 5Y8.8%
Sales Q2Q%-2.03%

3.2 Future

Based on estimates for the next years, EAD will show a very strong growth in Earnings Per Share. The EPS will grow by 43.35% on average per year.
EAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.50% yearly.
EPS Next Y62.16%
EPS Next 2Y64.4%
EPS Next 3Y43.35%
EPS Next 5YN/A
Revenue Next Year3.19%
Revenue Next 2Y1.38%
Revenue Next 3Y0.92%
Revenue Next 5Y-0.5%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EAD.DE Yearly Revenue VS EstimatesEAD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5M 10M 15M 20M 25M
EAD.DE Yearly EPS VS EstimatesEAD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EAD. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 15.92, EAD is valued correctly.
EAD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EAD is cheaper than 67.27% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EAD to the average of the S&P500 Index (23.18), we can say EAD is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.92
EAD.DE Price Earnings VS Forward Price EarningsEAD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

83.64% of the companies in the same industry are more expensive than EAD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EAD indicates a rather cheap valuation: EAD is cheaper than 94.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.67
EV/EBITDA 5.88
EAD.DE Per share dataEAD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

EAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EAD's earnings are expected to grow with 43.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.4%
EPS Next 3Y43.35%

0

5. Dividend

5.1 Amount

No dividends for EAD!.
Industry RankSector Rank
Dividend Yield N/A

ERLEBNIS AKADEMIE AG

FRA:EAD (10/20/2025, 7:00:00 PM)

4.18

-0.12 (-2.79%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-25 2025-08-25
Earnings (Next)11-25 2025-11-25
Inst Owners4.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.53M
Analysts80
Price Target12.85 (207.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-158.33%
EPS NY rev (3m)-156%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.92
P/S 0.42
P/FCF 2.67
P/OCF 2.09
P/B 0.62
P/tB 0.63
EV/EBITDA 5.88
EPS(TTM)-0.82
EYN/A
EPS(NY)0.26
Fwd EY6.28%
FCF(TTM)1.56
FCFY37.38%
OCF(TTM)2
OCFY47.82%
SpS9.97
BVpS6.69
TBVpS6.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.3%
ROE -12.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.64%
FCFM 15.68%
ROA(3y)-2.91%
ROA(5y)-1.16%
ROE(3y)-7.84%
ROE(5y)-3.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y-1.44%
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 5.77
Debt/EBITDA 4.24
Cap/Depr 20.36%
Cap/Sales 4.38%
Interest Coverage N/A
Cash Conversion 93.87%
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 2.15
Altman-Z 1.25
F-Score6
WACC5.18%
ROIC/WACCN/A
Cap/Depr(3y)91.53%
Cap/Depr(5y)193.86%
Cap/Sales(3y)22.47%
Cap/Sales(5y)53.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.29%
EPS Next Y62.16%
EPS Next 2Y64.4%
EPS Next 3Y43.35%
EPS Next 5YN/A
Revenue 1Y (TTM)5.54%
Revenue growth 3Y19.96%
Revenue growth 5Y8.8%
Sales Q2Q%-2.03%
Revenue Next Year3.19%
Revenue Next 2Y1.38%
Revenue Next 3Y0.92%
Revenue Next 5Y-0.5%
EBIT growth 1Y95.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2100%
EBIT Next 3Y177.35%
EBIT Next 5YN/A
FCF growth 1Y7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.81%
OCF growth 3Y19.45%
OCF growth 5Y0.92%